Iradimed Co (IRMD) support and resistance · P/E 51, rev $42.4M
Iradimed Co (IRMD) is a medical devices company listed on US.
This page maps Iradimed Co (IRMD) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported IRMD revenue for 2026-06-30 was $42.4M. Net income was $11.0M. Revenue was up 93.1% from 2026-03-31 to 2026-06-30. IRMD currently screens at market cap $1.19B and trailing P/E 50.9.
IRMD currently screens at market cap $1.19B and trailing P/E 50.9. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new IRMD 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the IRMD quote page for the session range and the stock page for the full model.
Not investment advice.